Pravin Dugel - 03 May 2023 Form 4 Insider Report for IVERIC bio, Inc.

Role: President, Director
Signature: Todd Anderman, as Attorney-in-Fact for Pravin U. Dugel
Issuer symbol: N/A
Transactions as of: 03 May 2023
Net transactions value: $0
Form type: 4
Filing time: 11 May 2023, 17:15:22 UTC
Previous filing: 04 Apr 2023
Next filing: 13 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISEE	Common Stock	Options Exercise	$0	+4,312	+2.2%	$0.000000	203,035	03 May 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ISEE	Restricted Stock Units	Options Exercise	$0	-4,312	-33%	$0.000000	8,625	03 May 2023	Common Stock	4,312		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units.
F2	On May 3, 2021, the Reporting Person was granted 17,250 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan.